Lumsdon K, Anderson H J
Hospitals. 1992 Dec 5;66(23):22-30.
A number of elements are transforming cancer care in hospitals. First is ongoing, rapid technological advance: Experts contend that biotechnology therapies will shift the site of cancer treatment from external, systemic treatments like radiation and chemotherapy, to targeted, tumor-specific drugs that boost the immune system. That change alone holds many implications for oncology management. In addition, an aging population, longer cancer survival rates, reimbursement concerns, and the increasing involvement of patients and their families in treatment decision making, will all have an impact on the way cancer care is designed and delivered. The time to plan, say experts, is now. Meanwhile, innovative treatment plans, patient care approaches, and collaborative efforts among institutions are moving hospital oncology into the 1990s in a dramatic way.
许多因素正在改变医院的癌症护理。首先是持续且迅速的技术进步：专家们认为，生物技术疗法将把癌症治疗的地点从外部的全身治疗，如放疗和化疗，转向增强免疫系统的靶向、针对肿瘤的药物。仅这一变化就对肿瘤学管理有诸多影响。此外，人口老龄化、癌症存活率提高、报销问题以及患者及其家属在治疗决策中日益增加的参与度，都将对癌症护理的设计和提供方式产生影响。专家们表示，现在是制定计划的时候了。与此同时，创新的治疗计划、患者护理方法以及各机构之间的协作努力正在以显著的方式将医院肿瘤学带入20世纪90年代。
